🇺🇸 FDA
Patent

US 9427578

Pharmacokinetics of iontophoretic sumatriptan administration

granted A61KA61K31/4045A61K9/0009

Quick answer

US patent 9427578 (Pharmacokinetics of iontophoretic sumatriptan administration) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Grant date
Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4045, A61K9/0009, A61K9/7023, A61P